International Journal of Molecular Medicine · 2020 · 19 citations · 39 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionHepatocellular CarcinomaLiver CancerMalignant NeoplasmsNoncoding Rna In CancerHepatocellular Carcinoma PathogenesisLong Noncoding Rna RegulationMalignant ProgressionMicrorna In CancerMicrorna ModulationMicrorna Regulation In CancerNoncoding Rna Expression ProfilingWestern Blot Analysis
Hepatocellular carcinoma (HCC) is an aggressively malignant type of cancer with a complex pathogenesis. Multiple studies have identified that lncRNA HOXA11‑AS is involved in the development of HCC. Nevertheless, the pathological mechanisms of HOXA11‑AS in the development of HCC require further investigation. In the present study, the role and underlying mechanisms of HOXA11‑AS in HCC were examined. RT‑qPCR revealed that HOXA11‑AS expression was increased, while that of miR‑506‑3p was decreased in HCC tissues and cells compared with that in adjacent non‑tumor tissues and normal hepatic cells. Dual‑luciferase reporter assay and RNA pull‑down assay indicated that HOXA11‑AS directly interacted with miR‑506‑3p. miR‑506‑3p downregulation reversed the inhibitory effects of HOXA11‑AS deletion on cell proliferation, invasion and epithelial‑mesenchymal transition (EMT), as shown by CCK‑8 and Transwell assays, as well as western blot analysis. Bioinformatics analysis and dual‑luciferase reporter assay indicated that Slug was a target gene of miR‑506‑3p. The overexpression of Slug reversed the effects of HOXA11‑AS deletion on the viability, invasion and the EMT of HCC cells. Taken together, the present study demonstrates that HOXA11‑AS functions as an oncogene to promote the progression of HCC via the miR‑506‑3p/Slug axis, providing a therapeutic target for patients with HCC.
39
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
Xia Zhao, Xiaoyou Li, Leilei Zhou et al. · Cancer Science · 2018 · 156 citations · Full text
Medicine, Cancer Biology, Oncology +17
Tiansong Liang, Yingjuan Zheng, Juan Wang et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 146 citations · Full text
Medicine, Cancer Biology, Oncology +17